Medicine

All Articles

Prenatal exposure to starvation affects long-lasting wellness

.Nature Medication, Released online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of da...

A global metric of immune health

.Attribute Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research ...

Niacin, food items consumption and cardio effects

.Nature Medicine, Posted online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, food items...

Opportunities as well as obstacles for patient-reported result analysis in multimorbidity study and practice

.Completing rate of interests.S.E.H. obtains backing from the National Principle of Health And Welln...

Hibernation science utilized to manage excessive weight and also customize metabolic process

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowing the...

CAR- T and also cellular gene treatments are actually as well costly

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care prod...

The WHO genomics program of work with fair implementation of human genomics for global health

.The publication of the initial draft of the human genome sequence in 20011 was adhered to due to th...

A time-stratified, case\u00e2 $ \"crossover research study of heat energy exposure and also perinatal death from 16 medical facilities in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in 4 sub-Saharan African nations, we monitored d...

Advancing worldwide antibiotic research study, growth as well as access #.\n\nMurray, C. J. L. et cetera. Worldwide problem of bacterial antimicrobial protection in 2019: an organized analysis. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. Towards certain dedications and also activity in the reaction to antimicrobial protection. International Frontrunners Group on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Globe Health And Wellness Institution. WHO posts list of microorganisms for which brand new prescription antibiotics are quickly required. Planet Health and wellness Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Health And Wellness Organization. That microbial top priority virus listing, 2024: bacterial microorganisms of public health value to assist study, growth as well as techniques to avoid and also handle antimicrobial resistance. Globe Health Company https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative access. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nGlobe Wellness Organization. 2023 anti-bacterial agents in medical as well as preclinical advancement: a summary and study. Globe Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Assessment. May 19, 2016 \u00e2 $\" Tackling drug-resistant contaminations around the world: ultimate file and also suggestions. Testimonial on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outcomes: files as well as briefing. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall structure: a call for concerted action on antibiotics trial and error. Boston ma Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Short 51: Exactly how can the EU help lasting innovation as well as accessibility to effective anti-biotics? plan options for existing and brand-new medicines. European Observatory on Health And Wellness Systems as well as Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic make use of and also resistance\u00e2 $\" proving the evident. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Wellness Company. 2021 Mindful classification. WHO access, check out, reserve, distinction of anti-biotics for analysis and monitoring of making use of. World Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Centre for Health Condition Protection and also Command. Antimicrobial protection intendeds: how can our experts reach all of them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health Organization. Absence of advancement readied to undermine antibiotic efficiency and wellness increases. Globe Health Organization https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. How antimicrobial protection is connected to climate improvement: an outline of 2 intertwined worldwide problems. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: our team need critical action as well as assets that focus on the weakest link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Organization. Booster shot coverage. Globe Health and wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection deterrence as well as command in low-resource setups: the necessity for the regional, the contextual as well as the pragmatic. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of implementing antimicrobial conservation resources in reduced to middle profit countries (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A short history of the antibiotic period: trainings learned and also problems for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Patient get access to in 14 high-income nations to new antibacterials approved by the US Fda, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Instruments Organization, or Health Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Company. 2021 anti-bacterial brokers in clinical as well as preclinical progression: an introduction and review. Planet Health Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the economics must sustain the science. Attributes 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of development in antibacterial therapies. Medical Technology Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Examining clinician use of next-generation antibiotics against immune Gram-negative contaminations in united state healthcare facilities: a retrospective accomplice research. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of advancement in antibacterial rehabs. Biotechnology Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical testimonial as well as essential assessment of motivation techniques for revelation and growth of unfamiliar prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nHealth Urgent Preparedness and Response Authorization. Trial and error of clinical countermeasures. European Payment https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Commission. Pre-draft proposal for an International relationship under Horizon Europe One Health Antimicrobial Protection. European Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Anti-biotic Experimentation Partnership. Entasis Therapies and also the Global Anti-biotic Research Study &amp Development Collaboration to cultivate a new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- and non-industry-sponsored clinical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Association. Lot of scientific test enrollments through area, condition, phase of growth, grow older and sex of trial attendees (1999\u00e2 $ \"2022). World Health Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Antibiotic Experimentation Alliance. NeoSept1: a study to determine the position of existing as well as brand-new anti-biotics combinations to treat newborn babies that remain in hospital with intense blood poisoning. ISRCTN computer registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Organization of Canada. Government of Canada makes necessary investment to combat antimicrobial resistance (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Prescription Antibiotic Trial And Error Relationship. Asia authorities funding supports GARDP\u00e2 $ s initiatives to counter antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Base. Novo Nordisk Groundwork companions along with CARB-X to eliminate drug-resistant infections. novo nordisk groundwork https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health as well as Digital Manager Agency. Research study on delivering AMR health care countermeasures to the marketplace. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Determining the ideal dimension of international pull motivations for antibacterial medications. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entrance reward for the growth of brand-new prescription antibiotics. Harvard Kennedy Institution https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Market rewards and antibiotic resistance: an introduction to the antibiotic sensitivity reward. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG advanced dedication for subscription-based acquiring of unfamiliar antimicrobials and also its own anticipated roi. Facility for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 assets in brand-new prescription antibiotics would certainly repay \u00e2 $\" for everyone. Workplace of Health Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up struggle against lethal infections observing prosperous world-first captain. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Percentage. Reform of the EU pharmaceutical legalisation. International Payment https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Compensation styles to tackle market failings for antimicrobials: methods absorbed France, Germany, Sweden, the United Kingdom, as well as the United States. Health and wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers as well as Affiliations. Coming from protection to durability: what could the future antibiotic pipeline resemble? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Center &amp Globe Health Association. Incentivising the development of brand-new antibacterial treatments: 2023 report card due to the Worldwide AMR R&ampD Center and WHO. Worldwide AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK subscription style for prescription antibiotics looked at prosperous? Lancet Microbe 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimuli for the growth and keeping the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, as well as nationwide sources of youngster mortality in 2000\u00e2 $ \"thirteen, along with estimates to update post-2015 top priorities: an improved step-by-step analysis. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et al. Anti-bacterial medicine deficiencies coming from 2001 to 2013: ramifications for professional training. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French reporting device for medication deficiencies: explanation and fads from 2012 to 2018: an empirical retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Analysis of that antibiotic consumption and also gain access to intendeds in 76 nations, 2000\u00e2 $ \"15: an analysis of pharmaceutical sales data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Battling the fakes: taking on substandard as well as falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring easier to get antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nBlack Community for Research Laboratory Medication. Plan concise as well as infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic consumption for human make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research. Trop. Med. Affect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial usage: evaluation of main warehouses items to in-patient treatment health and wellness facilities coming from 2017 to 2019 in Uganda. Trop. Medication. Contaminate. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et cetera. Variations in the usage of antimicrobial medicines in the European location, 2014\u00e2 $ \"2018: lookings for as well as ramifications coming from ESAC-Net and also WHO Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Medication shortage: causes, influence, and also reduction approaches. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client access in 14 high-income nations to brand new antibacterials permitted due to the United States Fda, European Medicines Firm, Japanese Pharmaceuticals and Medical Devices Firm, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et cetera. Lost anti-biotics: a follow-up stock study in Europe, the United States, Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness advancement for worldwide health and wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Sector Partnership. The 2023 AMR Market Partnership improvement survey: production and the atmosphere. amr Business Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can clinical products be actually cultivated on a non-profit basis? Discovering item growth alliances for disregarded illness. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Restart biomedical R&ampD in the international social interest. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Health Condition Control and also Prevention. Africa CDC pioneers strong relocate to get Africa\u00e2 $ s health future through producing a 50 billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health patent licensing agreements to raise accessibility to health and wellness technologies: an insider\u00e2 $ s tale. BMJ Chunk. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New organization designs for experimentation with cost demands are needed to accomplish decent rates of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Germs Biopharmaceutical Gas. Stewardship and also access. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Prescription Antibiotic Trial And Error Relationship. Shinogi, GARDP as well as CHAI introduce site license and also collaboration contracts to address microbial infections by broadening access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Collaboration. Leaving behind the laboratory: tracking the downtrend in AMR R&ampD specialists. amr Sector Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Health And Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 call to activity on antimicrobial protection. G7G20 Papers Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). International Union on Growing Old &amp Infectious Diseases Community of America. 2024 AMR preparedness mark report card. Evaluating federal government activity on AMR policy. Global Union on Growing old https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Meals as well as Agriculture Institution of the United Nations, United Nations Environment Program, Planet Health Organization &amp. Planet Organization for Pet Health And Wellness. Global data bank for tracking antimicrobial resistance (AMR): country self-assessment survey (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the pande...

Integrating liver endpoints in clinical tests of cardio and also renal health condition

.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewp...